Voici la liste des sources utilisées pour le contenu du site :
– J. Labenz, P. Chandrasoma, L.Knapp, and T.DeMeester. Proposed approach to the challenging management of progressive gastroesophageal reflux disease World J Gastrointest Endosc. 2018 Sep 16; 10(9): 175–183

– Jiménez P. et al.: Free radicals and antioxidant in reflux esophagitis and Barrett’s esophagus. World J Gastroenterol 2005 May,14;11(18):2697-703

– Costa H.O. et al.: Is there a relationship between the pH and volume of saliva and oesophageal pH-metry results. Dysphagia, 2005 Summer;20(3):175-81

– Irene Martinucci, Nicola de Bortoli, Edoardo Savarino, Andrea Nacci et al. Optimal treatment of laryngopharyngeal reflux disease. 2013 Nov; 4(6): 287–301.

– Michael F. Vaezi, John E. Pandolfino, Marcelo F. Vela, Nicholas J. Shaheen et al. White Paper AGA: Optimal Strategies to Define and Diagnose Gastroesophageal Reflux Disease. Gastroenterology, 2017, Volume 15, Issue 8, Pages 1162–1172

– Michael F. Vaezi, Yu-Xiao Yang, Colin W. Howden et al. Complications of Proton Pump Inhibitor Therapy. Gastroenterology, 2017, Volume 153, Issue 1, Pages 35–48

– Andrew M. Ong, Laura Chua, Yu Tien Wang et al. Diaphragmatic Breathing Exercises is Efficacious in the Treatment of Belching and Reflux Symptoms in Gerd Patients. 2017; Gastroenterology, Volume 152, Issue 5, Supplement 1, Page S63

– David Mitchell, Mohammad H. Derakhshan, Angela Wirz, Stuart A. Ballantyne, Kenneth E. McColl et al. Abdominal Compression by Waist Belt Aggravates Gastroesophageal Reflux Mainly by Impairing Esophageal Clearance. 2017; Gastroenterology, Vol. 152, Issue 5, S196–S197

– Janarthanan S et al. Clostridium difficile-associated diarrhea and proton pump inhibitor therapy: a metaanalysis. Am J Gastroenterol. 2012 Jul;107(7):1001-10

– Kwok CS et al. Risk of Clostridium difficile infection with acid suppressing drugs and antibiotics: metaanalysis. Am J Gastroenterol. 2012Jul;107(7):1011-9

– Laheij RJF, Sturkenboom MCJM, Hassing RJ, et al. Risk of community-acquired pneumonia and use of gastric acid-suppressive drugs. JAMA 2004;292:1955-60

– Kantor, E.D., Rehm, C.D., Haas, J.S. et al. Trends in prescription drug use among adults in the United States from 1999–2012. JAMA. 2015; 314: 1818–1831

– Schumock, G.T., Li, E.C., Suda, K.J. et al. National trends in prescription drug expenditures and projections for 2016. Am J Health Syst Pharm. 2016; 73: 1058–1075

– Eivind Ness-Jensen, Kristian Hveem, Hashem El-Serag, Jesper Lagergren et al. Lifestyle Intervention in Gastroesophageal Reflux Disease. 2016; Clinical Gastroenterology and Hepatology, Vol. 14, Issue 2, p175–182.e3

– Cats, A., Schenk, B.E., Bloemena, E. et al. Parietal cell protrusions and fundic gland cysts during omeprazole maintenance treatment. Hum Pathol. 2000; 31: 684–690

– Ronnie Fass. Alternative Therapeutic Approaches to Chronic Proton Pump Inhibitor Treatment. 2011; Clinical Gastroenterology and Hepatology, Vol. 10, Issue 4, p338–345

– Charles J. Sigmund, Edmund F. McNally et al. The Action of a Carminative on the Lower Esophageal Sphincter. 1969; Gastroenterology, Vol. 56, Issue 1, p13–18

– Nilsson, M., Johnsen, R., Ye, W., Hveem, K., Lagergren, J. (2004) Lifestyle related risk factors in the aetiology of gastro-oesophageal reflux. Gut 53: 1730–1735

– Terry, P., Lagergren, J., Ye, W., Wolk, A., Nyren, O. (2001) Inverse association between intake of cereal fiber and risk of gastric cardia cancer. Gastroenterology 120: 387–391

– El-Serag, H., Satia, J., Rabeneck, L. (2005) Dietary intake and the risk of gastro-oesophageal reflux disease: a cross sectional study in volunteers. Gut 54: 11–17

– Katz PO, Gerson LB, Vela MF. Guidelines for the diagnosis and management of gastroesophageal reflux disease. Am J Gastroenterol 2013;108(3):308-28

– Santé Canada, Inhibiteurs de la pompe à protons : risque de fractures osseuses, sur http://canadiensensante.gc.ca/recall-alert-rappel-avis/hc-sc/2013/26523a-fra.php#media-medias, consulté le 01-05-2018

– Benjamin Lazarus, MBBS1,2; Yuan Chen, MS1; Francis P. Wilson, MD, MS3; et al (2016)Proton Pump Inhibitor Use and the Risk of Chronic Kidney Disease. JAMA Intern Med. 2016;176(2):238-246

– Willy Gomm; Klaus von Holt, MD; Friederike Thomé; et al. Association of Proton Pump Inhibitors With Risk of Dementia. JAMA Neurol. 2016;73(4):410-416

– Dam G, Vilstrup H, Watson H, Jepsen P. Proton pump inhibitors as a risk factor for hepatic encephalopathy and spontaneous bacterial peritonitis in patients with cirrhosis with ascites.Hepatology 2016;64:1265-1272

– Haenisch, B., Holt, von, K., Wiese, B., Prokein, J., Lange, C., Ernst, A., et al (2015). Risk of dementia in elderly patients with the use of proton pump inhibitors. European Archives of Psychiatry and Clinical Neuroscience 265, 419–428

– Gomm, W., Holt, von, K., Thomé, F., Broich, K., Maier, W., Fink, A., Doblhammer, G., Haenisch, B., (2016). Association of Proton Pump Inhibitors With Risk of Dementia: A Pharmacoepidemiological Claims Data Analysis. JAMA Neurol 73, 410–416.

– Shah NH, LePendu P, Bauer-Mehren A, Ghebremariam YT et al. Proton Pump Inhibitor Usage and the Risk of Myocardial Infarction in the General Population. PLoS ONE, 2015, 10(6)

– S Dial JAC Delaney AN Barkun Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease. JAMA 2005 (294)

– RB Canani P Cirillo P Roggero Therapy with gastric acidity inhibitors increases the risk of acute gastroenteritis and communityacquired pneumonia in children. Pediatrics 2006

– J Leonard JK Marshall P. Moayyedi Systematic review of the risk of enteric infection in patients taking acid suppression. Am J Gastroenterol 2007

– T Ali DN Roberts WM. Tierney Long-term safety concerns with proton pump inhibitors. Am J Med 2009 (122)

– C ** Bourne B Charpiat N Charhon Effets indésirables émergents des inhibiteurs de la pompe à protons. Presse Med 2013

– MD Howell V Novack P Grgurich Iatrogenic gastric acid suppression and the risk of nosocomial Clostridium difficile infection. Arch Intern Med 2010 (170)

– Dam G, Vilstrup H, Watson H, Jepsen P4. Proton pump inhibitors as a risk factor for hepatic encephalopathy and spontaneous bacterial peritonitis in patients with cirrhosis with ascites. Hepatology. 2016 Oct;64(4):1265-72

– Kamolz T, Velanovich V. Psychological and emotional aspects of gastroesophageal reflux disease. Dis Esophagus. 2002;15:199–203.

– Lee SP, Sung IK, Kim JH, Lee SY, Park HS, Shim CS. The effect of emotional stress and depression on the prevalence of digestive diseases. J Neurogastroenterol Motil. 2015;21:273–282. doi: 10.5056/jnm14116.

– Katz PO1, Gerson LB, Vela MF. Guidelines for the diagnosis and management of gastroesophageal reflux disease. Division of Gastroenterology, Einstein Medical Center, Philadelphia, Pennsylvania, USA.

– Song EM, Jung HK, Jung JM. The association between reflux esophagitis and psychosocial stress. Dig Dis Sci. 2013 Feb;58(2):471-7.

– Johnston BT, McFarland RJ, Collins JS, Love AH. Effect of acute stress on oesophageal motility in patients with gastro-oesophageal reflux disease. Gut. 1996 Apr; 38(4):492-7.

– Richter JE, Bradley LC. Psychophysiological interactions in esophageal diseases.Semin Gastrointest Dis. 1996 Oct; 7(4):169-84.

– Fass R, Naliboff BD, Fass SS, Peleg N, Wendel C, Malagon IB, Mayer EA. The effect of auditory stress on perception of intraesophageal acid in patients with gastroesophageal reflux disease. Gastroenterology. 2008 Mar; 134(3):696-705.

– Debra A. Zellner,Susan Loaiza,Zuleyma Gonzalez,Jaclyn Pita,Janira Morales,Deanna Pecora,Amanda Wolf. Physiology & Behavior – Food selection changes under stress. Volume 87, Issue 4, 15 April 2006, Pages 789-793

– American Society for Gastrointestinal Endoscopy, https://www.asge.org/home/for-patients/patient-information/understanding-gerd-barrett-39-s

– Cem Sahin, Fatih Akın, Nesat Cullu, Burak Özseker, İsmail Kirli and İbrahim. Large Intra-Abdominal Hiatal Hernia as a Rare Cause of Dyspnea. Case Rep Cardiol. 2015

– Jing-Xi Zhang, Xian-Bao Zhan, Chong Bai, and Qiang Li. Belching, regurgitation, chest tightness and dyspnea: Not gastroesophageal reflux disease but asthma. World J Gastroenterol. 2015 Feb 7

– Gajanan S. Gaude. Pulmonary manifestations of gastroesophageal reflux disease. Ann Thorac Med. 2009 Jul-Sep